Careers

Diversity

With 18 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

John Carney Chairs and Speaks, Jimmy Fokas Speaks at PLI Basics of Accounting for Lawyers 2025

Webinar Series: Transforming Legacy Management Experience

Rebecca Schrote Presents on APEX Depositions at Columbus Bar Association CLE Session

To Help the New Administration Help Your Industry, You Need an Agency Strategy (Real Estate Finance Journal)

As announced on June 9, 2022, Partner Adam Finerman and BakerHostetler represented Pulse Biosciences Inc. in a public rights offering pursuant to which Pulse sold more than 7 million units for an aggregate of more than $15 million, with each unit consisting of one share and one warrant to purchase a share. Pulse Biosciences is a bioelectric medicine company commercializing its CellFX® System, powered by Pulse’s proprietary Nano-Pulse Stimulation™. Initial commercial use of the CellFX System has been in dermatologic conditions.  <a href="https://www.businesswire.com/news/home/20220609006029/en/">More information</a>

Adam Finerman Represents Pulse Biosciences in Public Rights Offering

Featured Insights

Related Services

Featured Insights